Dynavax Technologies Corp 8-K Report: Key Stock Insights & Contact Info

Based on the provided section of the financial report for Dynavax Technologies Corp, here are the key insights:

1. Entity Identification:

• Company Name: Dynavax Technologies Corp
• CIK Number: 0001029142
• SEC Filing Type: 8-K
• Filing Date: February 19, 2025

2. Stock Information:

• Common Stock: The company has common stock with a par value of $0.001.
• Stock Ticker: DVAX
• Exchange: The common stock is listed on NASDAQ.
• Preferred Stock: The report also mentions "Preferred Share Purchase Rights," indicating the presence of preferred stock-related instruments.

3. Contact Information:

• Address: 2100 Powell Street, Suite 720, Emeryville, CA 94608
• Phone Number: 510-848-5100

4. Context and Dimensional Information:

• The report includes references to specific dimensions regarding the classes of stock, namely:
• • Common Stock Member: This indicates the reporting of common stock.
  • Preferred Stock Member: This indicates the reporting of preferred stock.

5. Reporting Period:

• The context indicates a reporting date of February 19, 2025, suggesting that this filing addresses events or updates pertinent to that specific date.

6. Other Details:

• The report seems to indicate that certain statements are either true or false, but specific details regarding these assertions are not provided in the excerpt.

Summary:

The financial report for Dynavax Technologies Corp highlights key elements such as its stock classification, contact details, and the nature of the filing. It is essential for investors and analysts to note the specific date of the report and the underlying stock structures as these can influence investment decisions and corporate governance assessments.